TRCT
LFST icon

Tower Research Capital (TRC)’s Lifestance Health LFST Stock Holding History

Tower Research Capital (TRC)’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.1K Buy
11,010
+8,900
+422% +$61.9K ﹤0.01% 2462
2025
Q4 		$14.9K Sell
2,110
-2,773
-57% -$16.7K ﹤0.01% 3328
2025
Q3 		$26.9K Sell
4,883
-15,624
-76% -$76.6K ﹤0.01% 3048
2025
Q2 		$106K Buy
20,507
+16,893
+467% +$101K ﹤0.01% 2329
2025
Q1 		$24.1K Buy
3,614
+713
+25% +$5.42K ﹤0.01% 2796
2024
Q4 		$21.4K Sell
2,901
-9,316
-76% -$66.9K ﹤0.01% 3137
2024
Q3 		$85.5K Sell
12,217
-4,655
-28% -$28K ﹤0.01% 2344
2024
Q2 		$82.8K Buy
16,872
+15,088
+846% +$91K ﹤0.01% 2715
2024
Q1 		$11K Sell
1,784
-22,176
-93% -$149K ﹤0.01% 3616
2023
Q4 		$188K Buy
23,960
+21,657
+940% +$140K ﹤0.01% 2161
2023
Q3 		$15.8K Sell
2,303
-5,175
-69% -$41.9K ﹤0.01% 3592
2023
Q2 		$68.3K Buy
7,478
+5,003
+202% +$41.6K ﹤0.01% 2322
2023
Q1 		$18K Sell
2,475
-1,982
-44% -$11K ﹤0.01% 3563
2022
Q4 		$22K Sell
4,457
-2,262
-34% -$14K ﹤0.01% 3046
2022
Q3 		$45K Buy
6,719
+1,618
+32% +$11.3K ﹤0.01% 3258
2022
Q2 		$28K Buy
5,101
+4,258
+505% +$32.6K ﹤0.01% 3447
2022
Q1 		$9K Sell
843
-541
-39% -$4.75K ﹤0.01% 4465
2021
Q4 		$14K Buy
1,384
+1,034
+295% +$11K ﹤0.01% 4081
2021
Q3 		$5K Buy
350
+50
+17% +$963 ﹤0.01% 4866
2021
Q2 		$8K Buy
+300
New +$7.92K ﹤0.01% 4492

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Tower Research Capital (TRC)'s LFST Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Lifestance Health (LFST) stake by 422% in Q1 2026, buying an estimated $61.9K and bringing the position to 11,010 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2462.

Tower Research Capital (TRC) first reported a position in LFST in Q2 2021 and has held it in 20 quarters since. The position peaked at $188K in Q4 2023. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Tower Research Capital (TRC) held 11,010 shares of Lifestance Health worth $70.1K as of Q1 2026.
  • Tower Research Capital (TRC) bought 8,900 Lifestance Health shares in Q1 2026, an estimated $61.9K.
  • Lifestance Health made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2462 holding.
  • Tower Research Capital (TRC) first reported a position in Lifestance Health in Q2 2021 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Lifestance Health position peaked at $188K in Q4 2023.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.